Thursday, October 19, 2017
 
 
MilliporeSigma Brings Customers Closer to Gene Therapy Product Commercialization
- Company's Carlsbad manufacturing facility passes FDA and EMA inspections
 
Patients with Serious Mental Health Conditions Receive Preventive Care at Rates Similar to Those Without These Conditions
PORTLAND, Ore., Oct. 19, 2017 /PRNewswire/ -- People with schizophrenia and bipolar disorder received preventive health screenings at rates similar to or higher than people without mental illnesses, according to a study of more than 800,000 patients published today in the American Journal of Preventive Medicine.
 
Bonnie J. Addario Lung Cancer Foundation and International Association for the Study of Lung Cancer Award Johns Hopkins School of Medicine Researcher $300,000
SAN CARLOS, Calif., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the International Association for the Study of Lung Cancer (IASLC) today announced the winner of the $300,000 ALCF-IASLC Second Joint International Fellowship Award for The Early D.....
 
Allergy Diagnostics And Therapeutics Market to Witness Significant Growth at a CAGR of over 12% by 2022 | Hexa Research
The global Allergy Diagnostics And Therapeutics Market is anticipated to grow at a CAGR exceeding 12% during the forecast period (2016 to 2022). This a...
 
Chemotherapy induced neutropenia Market to Register Substantial Expansion and Growth by 2025- Credence Research
According to the latest market report published by Credence Research, Inc. ?Chemotherapy induced neutropenia  Market - Growth, Future Prospects and Com...
 
Phototherapy Equipment Market Market to Register Substantial Expansion and Growth by 2025- Credence Research
According to the latest market report published by Credence Research, Inc. ?Phototherapy Equipment Market - Growth, Future Prospects, and Competitive A...
 



Novo Nordisk receives positive 16-0 vote from FDA Advisory Committee in favor of approval for semaglutide
PLAINSBORO, N.J., Oct. 18, 2017 /PRNewswire/ -- Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) voted 16-0, supporting the approval of once-weekly semaglutide to improve glycemic control in adults with type 2 diabetes. On.....
 
Global Down Syndrome Foundation Thanks Congressional Leaders for Scheduling Hearing on the Importance of Down Syndrome Research and its Potential for Discoveries Across Major Diseases
WASHINGTON, Oct. 18, 2017 /PRNewswire/ -- The Global Down Syndrome Foundation thanked Chairman Tom Cole (R-OK) and Ranking Member Rosa DeLauro (D-CT) for scheduling a hearing on Down syndrome research with the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human S.....
 
FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma
SILVER SPRING, Md., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of t.....
 
Mary's Nutritionals Introduces Two New Hemp-Infused Supplements
DENVER, Oct. 18, 2017 /PRNewswire/ -- Mary's Nutritionals today announced its newest cannabinoid innovationtwo variations of organic, hemp-infused supplements that utilize the powerful combination of activated hemp extract, vitamins and minerals to offer increased bioavailability, ensuring the consumer sufficiently receives.....
 
Mallinckrodt To Present At The Stifel 2017 Healthcare Conference
STAINES-UPON-THAMES, England, Oct. 18, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Nov. 14, 2017, at the Stifel 2017 Healthcare .....
 
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

LONDON, Oct. 18, 2017 /PRNewswire/ -- What is this Report About?

 


 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines